| PERIOD ENDING | 30-Jun-08 | 31-Mar-08 | 31-Dec-07 | 30-Sep-07 | | Total Revenue | 804,000 | 1,128,000 | 1,502,000 | 640,000 | | Cost of Revenue | 296,000 | 463,000 | 781,000 | 395,000 | | | Gross Profit | 508,000 | 665,000 | 721,000 | 245,000 | | | Operating Expenses | | Research Development | 356,000 | 316,000 | 321,000 | 258,000 | | Selling General and Administrative | 212,000 | 218,000 | 308,000 | 248,000 | | Non Recurring | 22,000 | 156,000 | 78,000 | 5,000 | | Others | 15,000 | 13,000 | 7,000 | 7,000 | | | | Total Operating Expenses | 605,000 | 703,000 | 714,000 | 518,000 | | | | Operating Income or Loss | (97,000) | (38,000) | 7,000 | (273,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 9,000 | (98,000) | 20,000 | 31,000 | | Earnings Before Interest And Taxes | (88,000) | (136,000) | 27,000 | (242,000) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (88,000) | (136,000) | 27,000 | (242,000) | | Income Tax Expense | 7,000 | (43,000) | 60,000 | (46,000) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (95,000) | (93,000) | (33,000) | (196,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (95,000) | (93,000) | (33,000) | (196,000) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($95,000) | ($93,000) | ($33,000) | ($196,000) |
|
1.49% Nasdaq 
0.27%
Income Statement
